Igor Odintsov

14PUBLICATIONS
141CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 28, 2026
MITF Activation Is a Feature of Clear Cell and Conventional Fibrous Papule.

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|Jun 18, 2026
Clinicopathological and molecular features of uterine smooth muscle tumours in patients with Li-Fraumeni syndrome.

|Jun 04, 2025
Genetic correlates of malignancy in TFE3-rearranged PEComa: a series of 14 cases.

David J Papke, Igor Odintsov, Navin R Mahadevan

|Apr 09, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.

Seshiru Nakazawa, Federica Pecci, Igor Odintsov

|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov

Pageof 3

Frequent Collaborators

3 joint publications

Edoardo Garbo

3 joint publications

Romel Somwar

3 joint publications

David J Papke

3 joint publications

Marc Ladanyi